Kutki for Anti-Inflammatory

Research suggests that Kutki (Picrorhiza kurroa) and its close botanical relative Neopicrorhiza scrophulariiflora possess anti-inflammatory properties, with the evidence coming primarily from narrative reviews and in vitro laboratory studies rather than clinical trials. Two reviews covering research published between 2010 and 2020 consistently identify anti-inflammatory activity among the reported pharmacological effects of these plants, attributing this activity to iridoid glycosides — particularly picrosides — as well as phenolic and flavonoid compounds found in the root. Studies indicate that the biological activity of kutki extracts varies depending on the solvent used in preparation, with methanolic extracts generally outperforming ethanol and water-based extracts across multiple measures, though this work focused primarily on antioxidant and antidiabetic endpoints rather than inflammation directly. The overall body of evidence is limited by its reliance on reviews of preclinical research, a near-complete absence of randomized controlled trials in humans, and the acknowledged need for more rigorous clinical investigation before firm conclusions about anti-inflammatory efficacy can be drawn.